Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study

Por Tsai, H.-T., Isaacs, C., Fu, A. Z., Warren, J. L., Freedman, A. N., Barac, A., Huang, C.-Y., Potosky, A. L.
Publicado em 2014

Using an Automated Recruitment Process to Generate an Unbiased Study Sample of Multiple Sclerosis Patients

Por Miller, Deborah M., Fox, R., Atreja, A., Moore, S., Lee, J.-C., Fu, A.Z., Jain, A., Saupe, W., Chakraborty, S., Stadtler, M., Rudick, R.A.
Publicado em 2010

Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study

Por Tsai, H.-T., Marshall, J. L., Weiss, S. R., Huang, C.-Y., Warren, J. L., Freedman, A. N., Fu, A. Z., Sansbury, L. B., Potosky, A. L.
Publicado em 2013